Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alchemy 43 is a private U.S. medical aesthetics and wellness company operating a multi-location clinic network focused on cosmetic "microtreatments." The company offers personalized aesthetic and wellness services including neuromodulator injections such as Botox and Dysport, dermal fillers, Sculptra, SKINVIVE, PRP-based treatments, laser and light procedures, microneedling, chemical peels, NAD+ and vitamin/peptide injections, and medical weight-loss services. Founded by Nicci Levy, Alchemy 43 positions itself at the intersection of beauty, wellness, and healthcare, emphasizing subtle, natural-looking results delivered by licensed medical providers. The business appears to be service-based rather than a drug-development biotech, with active operations across California, New York, and Texas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alchemy 43.